Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Brookfield and GATX acquire Wells Fargo’s $4.4bn railcar portfolio in strategic deal
Brookfield and GATX acquire Wells Fargo’s $4.4bn railcar portfolio in strategic deal Brookfield Infrastructure Partners and GATX Corporation have agreed to acquire the $4.4bn railcar portfolio of Wells Fargo, marking a major strategic shift for the US banking group....
Private equity adapts as Trump tariffs reshape global dealmaking landscape
Private equity adapts as Trump tariffs reshape global dealmaking landscape Private equity dealmaking has hit a roadblock as US President Donald Trump’s tariff policies derail a long-anticipated recovery, according to projections by Bain & Company. The value of...
HSBC injects $4bn into private credit funds as it eyes $50bn platform buildout
HSBC injects $4bn into private credit funds as it eyes $50bn platform buildout HSBC has announced a $4bn investment into its private credit funds, part of a broader push by banks to tap into the booming $2tn global private credit market. The capital will be channelled...




